Lee T. Schalop
Vorstandsvorsitzender bei Oncoceutics, Inc.
Profil
Lee T.
Schalop is the founder of Oncoceutics, Inc. (founded in 2009) and currently holds the position of Chief Executive Officer.
He is also currently working as the Director & Head-Business Development at ImmunoGenes AG and as a Director at The New York Chapter of the Inst of Internal Auditors, Inc. Dr. Schalop has previously worked as a Director at Velocity Commercial Capital LLC, Juvenile Diabetes Research Foundation Canada, and as an Analyst at JPMorgan Securities LLC and Banc of America Securities LLC.
He has also worked as a Research Analyst at Credit Suisse First Boston Corp.
Dr. Schalop holds a doctorate degree from Albert Einstein College of Medicine, Inc. and undergraduate degrees from The Wharton School of the University of Pennsylvania and The College of Arts & Sciences.
Aktive Positionen von Lee T. Schalop
Unternehmen | Position | Beginn |
---|---|---|
ImmunoGenes AG | Direktor/Vorstandsmitglied | - |
The New York Chapter of the Inst of Internal Auditors, Inc. | Direktor/Vorstandsmitglied | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Vorstandsvorsitzender | 01.01.2020 |
Ehemalige bekannte Positionen von Lee T. Schalop
Unternehmen | Position | Ende |
---|---|---|
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Headquartered in Charlotte, North Carolina, Banc of America Securities (BAS) is the investment banking subsidiary of Bank of America Corp (NYSE: BAC). The firm provides both the domestic and international equity and investment banking markets, and pursues a strategy pioneered by Citigroup that combines corporate lending with investment banking advice and services. They provide high-yield debt underwriting and leveraged finance, in addition to industry coverage groups such as healthcare, media and telecom, financial institutions, real estate and gaming. BAS also does a significant amount of work for Financial Sponsors, or private equity firms, often financing leveraged transactions. Following the strategy of Goldman Sachs, the firm lacks a standalone mergers and acquisitions department, instead employing mergers and acquisitions senior bankers throughout the industry coverage groups. The firm is registered as a broker/dealer with the SEC, is a member of the NYSE, and the NASD. The use of Banc in the BAS's name is indicative of the fact that the company is not a bank, and their deposits and other holdings are not insured by the FDIC. | Analyst-Equity | 11.06.2004 |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analyst-Equity | 25.09.2002 |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | - |
Juvenile Diabetes Research Foundation Canada
Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Velocity Commercial Capital LLC
Velocity Commercial Capital LLC Real Estate Investment TrustsFinance Velocity Commercial Capital LLC engages in the provision of investment property loans for residential, multi-family, mixed-use and small commercial properties. Its mortgage programs include FlexPerm Loan, ARV Pro Loan, Credit QuickFix Loan, Fast50 Loan, and Foreign Investor Loan. The company was founded by Jeffrey T. Taylor and Christopher D. Farrar in June 2004 and is headquartered in Westlake Village, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lee T. Schalop
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
The College of Arts & Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 8 |
---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Velocity Commercial Capital LLC
Velocity Commercial Capital LLC Real Estate Investment TrustsFinance Velocity Commercial Capital LLC engages in the provision of investment property loans for residential, multi-family, mixed-use and small commercial properties. Its mortgage programs include FlexPerm Loan, ARV Pro Loan, Credit QuickFix Loan, Fast50 Loan, and Foreign Investor Loan. The company was founded by Jeffrey T. Taylor and Christopher D. Farrar in June 2004 and is headquartered in Westlake Village, CA. | Finance |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Headquartered in Charlotte, North Carolina, Banc of America Securities (BAS) is the investment banking subsidiary of Bank of America Corp (NYSE: BAC). The firm provides both the domestic and international equity and investment banking markets, and pursues a strategy pioneered by Citigroup that combines corporate lending with investment banking advice and services. They provide high-yield debt underwriting and leveraged finance, in addition to industry coverage groups such as healthcare, media and telecom, financial institutions, real estate and gaming. BAS also does a significant amount of work for Financial Sponsors, or private equity firms, often financing leveraged transactions. Following the strategy of Goldman Sachs, the firm lacks a standalone mergers and acquisitions department, instead employing mergers and acquisitions senior bankers throughout the industry coverage groups. The firm is registered as a broker/dealer with the SEC, is a member of the NYSE, and the NASD. The use of Banc in the BAS's name is indicative of the fact that the company is not a bank, and their deposits and other holdings are not insured by the FDIC. | Finance |
Credit Suisse First Boston Corp. | Finance |
Juvenile Diabetes Research Foundation Canada
Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Canada focuses on type 1 diabetes (T1D) research. The company was founded in 1974 and is headquartered in Toronto, Canada. | Commercial Services |
ImmunoGenes AG | |
The New York Chapter of the Inst of Internal Auditors, Inc. | |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |